Related references
Note: Only part of the references are listed.Precision psychotherapy
Anabel Martinez-Aran et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Cannabis use and psychosis susceptibility: A call to action
Albert Batalla et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Early intervention comes late
Eduard Vieta et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Efficacy of Agomelatine 25-50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
Dan J. Stein et al.
ADVANCES IN THERAPY (2021)
The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds
Silvia Amoretti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years
Norma Verdolini et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis
Itxaso Gonzalez-Ortega et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Cannabis use and psychosis: a review of reviews
Alkomiet Hasan et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review
Sanne J. van der Steur et al.
BRAIN SCIENCES (2020)
The impact of sex and cannabis on clinical features in first-admitted patients with psychosis
Sara Arranz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: Data from the national RAISE-ETP study
Oladunni Oluwoye et al.
EARLY INTERVENTION IN PSYCHIATRY (2019)
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis
Miquel Bioque et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort
E. Setien-Suero et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder
C. M. Bonnin et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
Musa Basseer Sami et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial
Corinne Cather et al.
PSYCHIATRY RESEARCH (2018)
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis
Tabea Schoeler et al.
PSYCHIATRY RESEARCH (2017)
Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis
E. Foglia et al.
PSYCHOLOGICAL MEDICINE (2017)
Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use
Hannah Myles et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2016)
Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study
Jennifer L. Seddon et al.
SCHIZOPHRENIA BULLETIN (2016)
Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis
Katherine Berry et al.
COMPREHENSIVE PSYCHIATRY (2016)
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients A Systematic Review
Sainza Garcia et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Arianna Marconi et al.
SCHIZOPHRENIA BULLETIN (2016)
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial
Itxaso Gonzalez-Ortega et al.
TRIALS (2016)
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Robin M. Murray et al.
WORLD PSYCHIATRY (2016)
Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
Rashmi Patel et al.
BMJ OPEN (2016)
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
Tabea Schoeler et al.
LANCET PSYCHIATRY (2016)
Social Functioning Trajectories of Young First-Episode Psychosis Patients with and without Cannabis Misuse: A 30-Month Follow-Up Study
Cesar Gonzalez-Blanch et al.
PLOS ONE (2015)
Measurements of Response, Remission, and Recovery in Schizophrenia and Examples for Their Clinical Application
Stefan Leucht
JOURNAL OF CLINICAL PSYCHIATRY (2014)
A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial
C. Barrowclough et al.
PSYCHOLOGICAL MEDICINE (2014)
Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation
J. M. Stone et al.
PSYCHOLOGICAL MEDICINE (2014)
Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial
L. Clausen et al.
PSYCHOLOGICAL MEDICINE (2014)
Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization
Amber L. Bahorik et al.
ADDICTION (2013)
Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial
C. R. Hjorthoj et al.
PSYCHOLOGICAL MEDICINE (2013)
A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness
Kevin Madigan et al.
SCHIZOPHRENIA RESEARCH (2013)
How to assess drugs in the treatment of acute bipolar mania?
Michel Bourin et al.
FRONTIERS IN PHARMACOLOGY (2013)
Continued Cannabis Use and Outcome in First-Episode Psychosis: Data From a Randomized, Open-Label, Controlled Trial
Gunnar Faber et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Motivational Intervention to Reduce Cannabis Use in Young People with Psychosis: A Randomized Controlled Trial
Charles Bonsack et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2011)
Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
Ana Gonzalez-Pinto et al.
SCHIZOPHRENIA BULLETIN (2011)
Validation and Use of the Functioning Assessment Short Test in First Psychotic Episodes
Itxaso Gonzalez-Ortega et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2010)
Impact of cannabis and other drugs on age at onset of psychosis
Ana Gonzalez-Pinto et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Abstinence and moderate use goals in the treatment of marijuana dependence
Brian E. Lozano et al.
ADDICTION (2006)
Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis
J. Edwards et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Validation of the Spanish versions of the Montgomery-Asberg Depression and Hamilton Anxiety Rating Scales
A Lobo et al.
MEDICINA CLINICA (2002)
Share Paper
